Search

Your search keyword '"Bhimani Z"' showing total 29 results

Search Constraints

Start Over You searched for: Author "Bhimani Z" Remove constraint Author: "Bhimani Z"
29 results on '"Bhimani Z"'

Search Results

1. Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.

2. Heterogeneous treatment effects of therapeutic-dose heparin in patients hospitalized for COVID-19

3. Long-term (180-day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP randomized clinical trial

4. Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.

5. Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial

6. Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19

7. Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 – Preliminary report

8. Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial

9. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19

10. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19

11. Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

12. Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients with COVID-19: A Randomized Clinical Trial.

13. Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

14. Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19

15. The randomized embedded multifactorial adaptive platform for community-acquired pneumonia (REMAP-CAP) study: rationale and design

16. Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial

17. Simvastatin in Critically Ill Patients with Covid-19.

18. Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials.

19. Sport mega-event fantasies to financialization: the case of Porto Maravilha.

20. Co-designing and pilot testing an infographic to support patients/families through the REMAP-CAP consent process: a mixed-methods study protocol.

21. Lessons from Canada's notice of compliance with conditions policy for the life-cycle regulation of drugs.

22. Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.

23. Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.

24. Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.

25. Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.

26. Learning health systems in primary care: a systematic scoping review.

27. Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.

28. The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and Design.

Catalog

Books, media, physical & digital resources